List of Tables
Table 1. Global Oligonucleotide Therapy-based Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antisense Oligonucleotides (ASO)
Table 3. Key Players of siRNA
Table 4. Key Players of mRNA
Table 5. Global Oligonucleotide Therapy-based Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oligonucleotide Therapy-based Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oligonucleotide Therapy-based Drug Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Oligonucleotide Therapy-based Drug Market Share by Region (2020-2025)
Table 9. Global Oligonucleotide Therapy-based Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Oligonucleotide Therapy-based Drug Market Share by Region (2026-2031)
Table 11. Oligonucleotide Therapy-based Drug Market Trends
Table 12. Oligonucleotide Therapy-based Drug Market Drivers
Table 13. Oligonucleotide Therapy-based Drug Market Challenges
Table 14. Oligonucleotide Therapy-based Drug Market Restraints
Table 15. Global Oligonucleotide Therapy-based Drug Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Oligonucleotide Therapy-based Drug Market Share by Players (2020-2025)
Table 17. Global Top Oligonucleotide Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapy-based Drug as of 2024)
Table 18. Ranking of Global Top Oligonucleotide Therapy-based Drug Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Oligonucleotide Therapy-based Drug Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Oligonucleotide Therapy-based Drug, Headquarters and Area Served
Table 21. Global Key Players of Oligonucleotide Therapy-based Drug, Product and Application
Table 22. Global Key Players of Oligonucleotide Therapy-based Drug, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oligonucleotide Therapy-based Drug Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Oligonucleotide Therapy-based Drug Revenue Market Share by Type (2020-2025)
Table 26. Global Oligonucleotide Therapy-based Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Oligonucleotide Therapy-based Drug Revenue Market Share by Type (2026-2031)
Table 28. Global Oligonucleotide Therapy-based Drug Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Oligonucleotide Therapy-based Drug Revenue Market Share by Application (2020-2025)
Table 30. Global Oligonucleotide Therapy-based Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Oligonucleotide Therapy-based Drug Revenue Market Share by Application (2026-2031)
Table 32. North America Oligonucleotide Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Oligonucleotide Therapy-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Oligonucleotide Therapy-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Oligonucleotide Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Oligonucleotide Therapy-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Oligonucleotide Therapy-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Oligonucleotide Therapy-based Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Oligonucleotide Therapy-based Drug Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Oligonucleotide Therapy-based Drug Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Oligonucleotide Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Oligonucleotide Therapy-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Oligonucleotide Therapy-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Oligonucleotide Therapy-based Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Oligonucleotide Therapy-based Drug Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Oligonucleotide Therapy-based Drug Market Size by Country (2026-2031) & (US$ Million)
Table 47. Sarepta Therapeutics Company Details
Table 48. Sarepta Therapeutics Business Overview
Table 49. Sarepta Therapeutics Oligonucleotide Therapy-based Drug Product
Table 50. Sarepta Therapeutics Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 51. Sarepta Therapeutics Recent Development
Table 52. Ionis Pharmaceuticals Company Details
Table 53. Ionis Pharmaceuticals Business Overview
Table 54. Ionis Pharmaceuticals Oligonucleotide Therapy-based Drug Product
Table 55. Ionis Pharmaceuticals Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 56. Ionis Pharmaceuticals Recent Development
Table 57. Alnylam Company Details
Table 58. Alnylam Business Overview
Table 59. Alnylam Oligonucleotide Therapy-based Drug Product
Table 60. Alnylam Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 61. Alnylam Recent Development
Table 62. Biogen Company Details
Table 63. Biogen Business Overview
Table 64. Biogen Oligonucleotide Therapy-based Drug Product
Table 65. Biogen Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 66. Biogen Recent Development
Table 67. Nippon Shinyaku Company Details
Table 68. Nippon Shinyaku Business Overview
Table 69. Nippon Shinyaku Oligonucleotide Therapy-based Drug Product
Table 70. Nippon Shinyaku Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 71. Nippon Shinyaku Recent Development
Table 72. Sobi Company Details
Table 73. Sobi Business Overview
Table 74. Sobi Oligonucleotide Therapy-based Drug Product
Table 75. Sobi Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 76. Sobi Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Oligonucleotide Therapy-based Drug Product
Table 80. Novartis Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. BioNTech Company Details
Table 83. BioNTech Business Overview
Table 84. BioNTech Oligonucleotide Therapy-based Drug Product
Table 85. BioNTech Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 86. BioNTech Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Oligonucleotide Therapy-based Drug Product
Table 90. Pfizer Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Moderna Therapeutics Company Details
Table 93. Moderna Therapeutics Business Overview
Table 94. Moderna Therapeutics Oligonucleotide Therapy-based Drug Product
Table 95. Moderna Therapeutics Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 96. Moderna Therapeutics Recent Development
Table 97. Jazz Pharmaceuticals Company Details
Table 98. Jazz Pharmaceuticals Business Overview
Table 99. Jazz Pharmaceuticals Oligonucleotide Therapy-based Drug Product
Table 100. Jazz Pharmaceuticals Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 101. Jazz Pharmaceuticals Recent Development
Table 102. CureVac Company Details
Table 103. CureVac Business Overview
Table 104. CureVac Oligonucleotide Therapy-based Drug Product
Table 105. CureVac Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 106. CureVac Recent Development
Table 107. Regulus Therapeutics Company Details
Table 108. Regulus Therapeutics Business Overview
Table 109. Regulus Therapeutics Oligonucleotide Therapy-based Drug Product
Table 110. Regulus Therapeutics Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 111. Regulus Therapeutics Recent Development
Table 112. ProQR Company Details
Table 113. ProQR Business Overview
Table 114. ProQR Oligonucleotide Therapy-based Drug Product
Table 115. ProQR Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 116. ProQR Recent Development
Table 117. Secarna Company Details
Table 118. Secarna Business Overview
Table 119. Secarna Oligonucleotide Therapy-based Drug Product
Table 120. Secarna Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 121. Secarna Recent Development
Table 122. MiNA Therapeutics Company Details
Table 123. MiNA Therapeutics Business Overview
Table 124. MiNA Therapeutics Oligonucleotide Therapy-based Drug Product
Table 125. MiNA Therapeutics Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 126. MiNA Therapeutics Recent Development
Table 127. Sylentis Company Details
Table 128. Sylentis Business Overview
Table 129. Sylentis Oligonucleotide Therapy-based Drug Product
Table 130. Sylentis Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 131. Sylentis Recent Development
Table 132. Arrowhead Company Details
Table 133. Arrowhead Business Overview
Table 134. Arrowhead Oligonucleotide Therapy-based Drug Product
Table 135. Arrowhead Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 136. Arrowhead Recent Development
Table 137. Silence Therapeutics Company Details
Table 138. Silence Therapeutics Business Overview
Table 139. Silence Therapeutics Oligonucleotide Therapy-based Drug Product
Table 140. Silence Therapeutics Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 141. Silence Therapeutics Recent Development
Table 142. Dicerna Company Details
Table 143. Dicerna Business Overview
Table 144. Dicerna Oligonucleotide Therapy-based Drug Product
Table 145. Dicerna Revenue in Oligonucleotide Therapy-based Drug Business (2020-2025) & (US$ Million)
Table 146. Dicerna Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. Oligonucleotide Therapy-based Drug Picture
Figure 2. Global Oligonucleotide Therapy-based Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oligonucleotide Therapy-based Drug Market Share by Type: 2024 VS 2031
Figure 4. Antisense Oligonucleotides (ASO) Features
Figure 5. siRNA Features
Figure 6. mRNA Features
Figure 7. Global Oligonucleotide Therapy-based Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Oligonucleotide Therapy-based Drug Market Share by Application: 2024 VS 2031
Figure 9. Neuromuscular Diseases Case Studies
Figure 10. hATTR Case Studies
Figure 11. COVID-19 Case Studies
Figure 12. Other Case Studies
Figure 13. Oligonucleotide Therapy-based Drug Report Years Considered
Figure 14. Global Oligonucleotide Therapy-based Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Oligonucleotide Therapy-based Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Oligonucleotide Therapy-based Drug Market Share by Region: 2024 VS 2031
Figure 17. Global Oligonucleotide Therapy-based Drug Market Share by Players in 2024
Figure 18. Global Top Oligonucleotide Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapy-based Drug as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Oligonucleotide Therapy-based Drug Revenue in 2024
Figure 20. North America Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Oligonucleotide Therapy-based Drug Market Share by Country (2020-2031)
Figure 22. United States Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Oligonucleotide Therapy-based Drug Market Share by Country (2020-2031)
Figure 26. Germany Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Oligonucleotide Therapy-based Drug Market Share by Region (2020-2031)
Figure 34. China Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Oligonucleotide Therapy-based Drug Market Share by Country (2020-2031)
Figure 42. Mexico Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Oligonucleotide Therapy-based Drug Market Share by Country (2020-2031)
Figure 46. Turkey Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Oligonucleotide Therapy-based Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Sarepta Therapeutics Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 50. Ionis Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 51. Alnylam Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 52. Biogen Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 53. Nippon Shinyaku Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 54. Sobi Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 55. Novartis Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 56. BioNTech Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 58. Moderna Therapeutics Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 59. Jazz Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 60. CureVac Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 61. Regulus Therapeutics Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 62. ProQR Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 63. Secarna Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 64. MiNA Therapeutics Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 65. Sylentis Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 66. Arrowhead Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 67. Silence Therapeutics Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 68. Dicerna Revenue Growth Rate in Oligonucleotide Therapy-based Drug Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
